<--- Back to Details
First PageDocument Content
Medicine / Biotechnology / Monoclonal antibodies / Glycoproteins / Monoclonal antibody therapy / Humanized antibody / Phage display / Fusion protein / Bispecific monoclonal antibody / Biology / Immunology / Immune system
Date: 2015-03-26 04:00:20
Medicine
Biotechnology
Monoclonal antibodies
Glycoproteins
Monoclonal antibody therapy
Humanized antibody
Phage display
Fusion protein
Bispecific monoclonal antibody
Biology
Immunology
Immune system

COVER CONFERENCE-AT-A-GLANCE Eleventh Annual HOTEL & TRAVEL

Add to Reading List

Source URL: www.giievent.kr

Download Document from Source Website

File Size: 2,79 MB

Share Document on Facebook

Similar Documents

Visterra to Present Data at ICAAC on VIS513, its Humanized Monoclonal Antibody That Targets a Conserved Site on the Dengue Virus E Protein ‒ VIS513 engineered to bind and potently neutralize all four serotypes of dengu

Visterra to Present Data at ICAAC on VIS513, its Humanized Monoclonal Antibody That Targets a Conserved Site on the Dengue Virus E Protein ‒ VIS513 engineered to bind and potently neutralize all four serotypes of dengu

DocID: 1v1w4 - View Document

Metadata Specifications: Antibodies Custom	Fields  Common	Fields

Metadata Specifications: Antibodies Custom Fields Common Fields

DocID: 1pqfc - View Document

Importance  Antibodies LINCS Field Name  1:  Required

Importance Antibodies LINCS Field Name 1:  Required

DocID: 1pbqh - View Document

THE UNIVERSITY OF NEW MEXICO COLLEGE OF PHARMACY ALBUQUERQUE, NEW MEXICO ?

THE UNIVERSITY OF NEW MEXICO COLLEGE OF PHARMACY ALBUQUERQUE, NEW MEXICO ?

DocID: 1p32j - View Document

Poster LFB AACR bis:Mise en page:09 Page1  Towards a new targeted therapy for ovarian cancer: development of an anti-human müllerian inhibiting substance type II receptor humanized antibody Alexandra Jacqu

Poster LFB AACR bis:Mise en page:09 Page1 Towards a new targeted therapy for ovarian cancer: development of an anti-human müllerian inhibiting substance type II receptor humanized antibody Alexandra Jacqu

DocID: 1d8zz - View Document